Search Results 591-600 of 21212 for anti-TNF drugs

  1. Temozolomide (Oral Route) Description and Brand Names - Mayo Clinic

    It belongs to the group of medicines known as antineoplastics (cancer medicines). ... Drugs & Supplements; Temozolomide (Oral Route). Your gift holds great power ...

  2. Histamine H2 Antagonist (Oral Route, Injection Route, Intravenous Route) Proper Use - Mayo Clinic

    These may be signs of a serious condition that may need different treatment. For patients taking the prescription strengths of these medicines for more serious ...

  3. Sumatriptan And Naproxen (Oral Route) Precautions - Mayo Clinic

    Using too much of this medicine or any other migraine medicines (eg, ergotamine, triptans, opioids, or a combination treatment for 10 or more days per month) ...

  4. Eating disorder treatment: Know your options - Mayo Clinic

    Depending on your eating disorder and its symptoms, treatment may include a mix of talk therapy, nutrition education and medicines.

  5. Ciltacabtagene Autoleucel (Intravenous Route) Precautions - Mayo Clinic

    If you can get pregnant, your doctor may do tests to make sure you are not pregnant before starting treatment. This medicine may cause cytokine release ...

  6. Corticosteroid (Inhalation Route) Description and Brand Names - Mayo Clinic

    This medicine may be used with other asthma medicines, such as bronchodilators (medicines that open up narrowed breathing passages) or other corticosteroids ...

  7. Carbidopa And Levodopa (Oral Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Parcopa; Rytary; Sinemet 10-100; Sinemet ...

  8. Neratinib (Oral Route) Proper Use - Mayo Clinic

    Continue taking these medicines for 2 cycles (56 days) of treatment with neratinib. Keep the number of your bowel movements at 1 to 2 per day and take anti- ...

  9. Sulfamethoxazole And Trimethoprim (Oral Route) Precautions - Mayo Clinic

    The results of some tests may be affected by this medicine. Patients receiving anticonvulsant treatment (medicines to prevent seizures) may be at risk for a ...

  10. Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects with Crohn's Disease and Who Participated and Successfully Completed M14-115 - Mayo Clinic

    This study will evaluate the long term efficacy, safety, and tolerability of repeated administration of adalimumab in subjects with Crohn's disease.